Amelia Named a Leader in the Gartner Magic Quadrant for Enterprise Conversational AI Platforms

Amelia, a leading Enterprise Conversational AI software company, announced that the company is named as a Leader in the Gartner Magic Quadrant for Enterprise Conversational AI Platforms. Gartner also positioned Amelia highest in the Leaders quadrant for its ability to execute on the company’s vision for its Conversational AI platform. The recognition is an important milestone in Amelia’s mission to create extraordinary customer experiences and improve IT operations for enterprises around the world.

The report identifies several Amelia capabilities in its positioning as a Conversational AI Platform Leader:

• Natural conversational experience design
• Designed for scale and high throughput
• Superlative process automation skills

Recommended AI News: PINC AI Launches INsights, an Enhanced Technology Offering for Customized, On-Demand Healthcare Analytics

The Leader recognition by Gartner is Amelia’s latest achievement. Last year, Amelia was cited as a market leader and awarded for industry excellence ten times by analyst firms for the capabilities of the Amelia Integrated Platform, which is purpose-built to help companies transform into friction-less digital enterprises utilizing Amelia’s Conversational AI and AIOps.

Chetan Dube, CEO of Amelia, said: “We know by working with our customers that Amelia creates superior value in customer service and IT Operations in ways that were previously unattainable, thanks to our innovative Conversational AI and Intelligent Automation capabilities. Amelia is directly positioned at a critical pivot point in the Future of Work, where human and digital workers collaborate to enable enhanced service, greater efficiency and extraordinary experiences for employees and customers alike. We’re honored that Gartner has recognized our Leader positioning among Conversational AI Platforms, giving confidence

Recommended AI News: Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

[To share your insights with us, please write to sghosh@martechseries.com]